Five Prime IPO carries on biotech boom
September 18, 2013 at 13:13 PM EDT
Five Prime Therapeutics Inc.'s $62 million stock debut Wednesday is getting good reviews on Wall Street so far, continuing the biotech industry's rise to investment favor...